Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage ...

This program supports undergraduate, graduate, and medical students conducting lupus-focused research under the guidance of experienced mentors.

This June, we recognize Men’s Health Month by honoring the strength, challenges and lived experiences of men with lupus.

In a new study, researchers identified eight disease activity domains for further development into the new Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE), a clinical trial ...

A new study found higher serum levels, specifically S100A8/A9, and not significantly MMP-9, in the blood, are associated with cognitive impairment (CI) in those with Systemic Lupus Erythematosus.

This study is being conducted to evaluate the safety, tolerability, and ability to manufacture Descartes-08, an investigational mRNA CAR-T cell therapy, in people living with moderate to severe ...

The Lupus & You: Empowerment conference is an experience that celebrates, inspires, supports, and uplifts lupus warriors, care partners, family, and friends. During this empowering day, attendees will ...

The purpose of this study is to evaluate the safety and efficacy of CNTY-101, an investigational “off-the-shelf” CD19 Chimeric Antigen Receptor (CAR) Natural Killer (NK)-cell therapy, in participants ...

Lupus is an unpredictable and misunderstood autoimmune disease. It is difficult to diagnose, hard to live with, and a challenge to treat. Lupus has a range of symptoms, and strikes without warning.

I will never forget feeling miserable on my 26th birthday. I knew something was wrong. After dinner with friends, I went to urgent care for blood work. A few days later, I got a phone call with the ...